| Company Name: |
NCE Biomedical Co.,Ltd. |
| Tel: |
4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988 |
| Email: |
|
| Company Name: |
SPIRO PHARMA |
| Tel: |
|
| Email: |
eric_feng1954@126.com |
| Company Name: |
BOC Sciences |
| Tel: |
16314854226 |
| Email: |
info@bocsci.com |
Ozarelix manufacturers
- Ozarelix
-
- $1520.00
-
2026-07-21
- CAS:295350-45-7
- Purity:
- Supply Ability: 10g
|
| | Ozarelix Basic information |
| Product Name: | Ozarelix | | Synonyms: | AC-D-2-NAL-D-4-CPA-D-3-PAL-SER-N-ME-TYR-D-HCI-NLE-ARG-PRO-D-ALA-NH2;Ozarelix;D 63153;D-63153;N-Acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-N-methyl-L-tyrosyl-N6-(aminocarbonyl)-D-lysyl-L-norleucyl-L-arginyl-L-prolyl-D-alaninamide;Ac-D-2-Nal-D-4-Cpa-D-3-Pal-Ser-N-Me-Tyr-D-Hci-Nle-Arg-Pro-D-Ala-NH2 acetate salt;Ozarelix Acetate;Ozarrelix | | CAS: | 295350-45-7 | | MF: | C72H96ClN17O14 | | MW: | 1459.09 | | EINECS: | | | Product Categories: | | | Mol File: | 295350-45-7.mol |  |
| | Ozarelix Chemical Properties |
| density | 1.40 | | pka | 9.82±0.15(Predicted) | | InChIKey | KATZUZNTRINHDT-HALMFYTRSA-N |
| | Ozarelix Usage And Synthesis |
| Uses | Ozarelix (D-63153) is a GnRH antagonist. Ozarelix induces cell apoptosis and arrests cell in G2/M phase. Ozarelix can be used in the research of prostate cancer[1]. | | References | [1] Festuccia C, et al. Ozarelix, a fourth generation GnRH antagonist, induces apoptosis in hormone refractory androgen receptor negative prostate cancer cells modulating expression and activity of death receptors. Prostate. 2010 Sep 1;70(12):1340-9. DOI:10.1002/pros.21169 |
| | Ozarelix Preparation Products And Raw materials |
|